Steve Engen Email & Phone

Chief Executive Officer @ Renexes LLC

@ Viridian Therapeutics, Inc.

@ Axsome Therapeutics, Inc.

Advisor @ Cerevel Therapeutics

Advisor @ Melinta Therapeutics

Advisor @ Inotrem

Advisor @ LIB Therapeutics

Advisor @ Oncorus

Advisor @ VivaVision Biotech, Inc.

Advisor @ Allay Therapeutics

Advisor @ Pieris Pharmaceuticals

Strategic Partner @ YAFO Capital

Japan Asia Advisor @ Verastem

Advisor @ Landos Biopharma, Inc.

Board Member @ Laevoroc

Advisor @ EQRx

Advisor @ Second Genome Inc.

Advisor @ Angion

Member of the Board of Directors (Independent Director) @ TMS Co., Ltd.

CEO @ Renegen KK

Managing Director @ Locust Walk

Managing Director Asia @ Locust Walk

Advisor @ Nichiiko Pharmaceutical Co., Ltd.

Vice President and Representative Director, Shire Japan @ Shire Pharmaceuticals

President and CEO @ Solasia Pharma K.K.

President and Representative Director, Mundipharma Japan @ Mundipharma

Senior Manager, Licensing @ Purdue Pharma L.P.

Product Development @ Ezaki Glico Co. Ltd.

Manager @ SoundOff Records

1998 - 2000 MBA @ Temple University

1985 - 1990 BS @ University of Utah

Japanese, Marketing Strategy, Pharmaceuticals, Biotechnology, Beginning Chinese, Company Building, Clinical Development, Pharmaceutical Industry, Lifesciences, Competitive Analysis, Drug Development, Product Launch, Clinical Trials, Management, Mergers & Acquisitions, Medical Devices, Regulatory Affairs, Regulatory Submissions, Negotiation, Oncology, Biopharmaceuticals, Cross-functional Team Leadership, Product Development, Drug Discovery, Pharmaceutics, Marketing, Technology Transfer, Market Research, Market Analysis, Strategy, Start-ups, Infectious Diseases, Business Development, Clinical Research, Licensing, CRO, Market Access, Chinese, Commercialization, Global Marketing, Start Ups, Cross Functional Team Leadership, Mergers and Acquisitions, Neurology, Life Sciences

Steve Engen, based in Bellevue, WA, US, is currently a Chief Executive Officer at Renexes LLC. Steve Engen brings experience from previous roles at Viridian Therapeutics, Inc., Axsome Therapeutics, Inc., Cerevel Therapeutics, Melinta Therapeutics, Inotrem, LIB Therapeutics, Oncorus, VivaVision Biotech, Inc., Allay Therapeutics, Pieris Pharmaceuticals, YAFO Capital, Verastem, Landos Biopharma, Inc., Laevoroc, EQRx, Second Genome Inc., Angion, TMS Co., Ltd., Renegen KK, Locust Walk, Locust Walk, Nichiiko Pharmaceutical Co., Ltd., Shire Pharmaceuticals, Solasia Pharma K.K., Mundipharma, Purdue Pharma L.P., Ezaki Glico Co. Ltd., SoundOff Records. Steve Engen holds various educational qualifications including MBA (1998 - 2000) from Temple University. With a robust skill set that includes Japanese, Marketing Strategy, Pharmaceuticals, Biotechnology, Beginning Chinese, Steve Engen demonstrates proficiency in a wide range of areas.